Literature DB >> 8905250

The clinical implications of inhibition of the inducible form of cyclo-oxygenase.

C Richardson1, P Emery.   

Abstract

There are 2 isoenzymes of cyclo-oxygenase (COX). There is a constitutive enzyme COX-1 which has a wide tissue distribution. In addition there is an inducible enzyme COX-2 which has a restricted tissue distribution. The inducible enzyme COX-2 is responsible for the generation of prostaglandins at sites of tissue inflammation and its inhibition is associated with an anti-inflammatory action. The constitutive enzyme, COX-1 is responsible for the production of prostaglandins with multiple functions. One well known and clinically important function is the gastroprotective effect of the prostaglandins produced in the gastric mucosa. While selective COX-2 inhibition may be associated with a reduced incidence of gastric adverse effects, a concern remains that its inhibition at other locations may be associated with other adverse effects.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8905250     DOI: 10.2165/00002018-199615040-00003

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  11 in total

Review 1.  Mechanisms of nonsteroidal anti-inflammatory drug-induced gastric damage.

Authors:  R T Schoen; R J Vender
Journal:  Am J Med       Date:  1989-04       Impact factor: 4.965

2.  Purification and characterization of a novel, distinct isoform of prostaglandin endoperoxide synthase induced by human chorionic gonadotropin in granulosa cells of rat preovulatory follicles.

Authors:  J Sirois; J S Richards
Journal:  J Biol Chem       Date:  1992-03-25       Impact factor: 5.157

3.  Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.

Authors:  J R Vane
Journal:  Nat New Biol       Date:  1971-06-23

4.  Inducible cyclooxygenase (COX-2): a safer therapeutic target?

Authors:  I Appleton; A Tomlinson; D A Willoughby
Journal:  Br J Rheumatol       Date:  1994-05

5.  Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase/cyclooxygenase gene.

Authors:  D A Kujubu; H R Herschman
Journal:  J Biol Chem       Date:  1992-04-25       Impact factor: 5.157

6.  Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing.

Authors:  W L Xie; J G Chipman; D L Robertson; R L Erikson; D L Simmons
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

7.  Involvement of tyrosine kinases in the induction of cyclo-oxygenase-2 in human endothelial cells.

Authors:  A Blanco; A Habib; S Levy-Toledano; J Maclouf
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

8.  Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs.

Authors:  E A Meade; W L Smith; D L DeWitt
Journal:  J Biol Chem       Date:  1993-03-25       Impact factor: 5.157

9.  Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids.

Authors:  L J Crofford; R L Wilder; A P Ristimäki; H Sano; E F Remmers; H R Epps; T Hla
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

10.  Induction of cyclooxygenase by interleukin 1: comparative study between human synovial cells and chondrocytes.

Authors:  I Knott; M Dieu; M Burton; A Houbion; J Remacle; M Raes
Journal:  J Rheumatol       Date:  1994-03       Impact factor: 4.666

View more
  3 in total

Review 1.  Cyclo-oxygenase isoenzymes. How recent findings affect thinking about nonsteroidal anti-inflammatory drugs.

Authors:  J Y Jouzeau; B Terlain; A Abid; E Nédélec; P Netter
Journal:  Drugs       Date:  1997-04       Impact factor: 9.546

2.  Decreased prostaglandin E2 synthesis by lung fibroblasts isolated from rats with bleomycin-induced lung fibrosis.

Authors:  F Ogushi; T Endo; K Tani; K Asada; T Kawano; H Tada; K Maniwa; S Sone
Journal:  Int J Exp Pathol       Date:  1999-02       Impact factor: 1.925

3.  Restorative impact of rabeprazole on gastric mucus and mucin production impairment during naproxen administration: its potential clinical significance.

Authors:  T Jaworski; I Sarosiek; S Sostarich; K Roeser; M Connor; S Brotze; G Wallner; J Sarosiek
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.